Press Releases

Press Releases

    Date Title View
    01/30/23
    Summary ToggleHorizon Therapeutics plc to Release Fourth-Quarter and Full-Year 2022 Financial Results on March 1, 2023
    PDF Version
    01/27/23
    Summary ToggleRule 15 (c) Announcement – Horizon Therapeutics plc
    PDF Version
    01/23/23
    Summary ToggleRule 17 (b) Announcement – Horizon Therapeutics plc
    PDF Version
    01/23/23
    Summary ToggleRule 17 (a) Announcement – Horizon Therapeutics plc
    PDF Version
    01/18/23
    Summary ToggleHorizon Therapeutics plc Announces Phase 2 Trial Evaluating Dazodalibep for the Treatment of Sjögren’s Syndrome Meets Primary Endpoint in the Second Study Population; Only Phase 2 Trial to Meet Primary Endpoint in Both Patient Populations
    PDF Version
    01/12/23
    Summary ToggleRule 2.12 Announcement – Horizon Therapeutics plc
    PDF Version
    01/06/23
    Summary ToggleRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
    01/06/23
    Summary ToggleRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
    01/06/23
    Summary ToggleRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
    01/06/23
    Summary ToggleRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
    Displaying 1 - 10 of 14 results